Human Cardiac Progenitor Cell Grafts as Unrestricted Source of Supernumerary Cardiac Cells in Healthy Murine Hearts

Laboratorio di Cardiologia Molecolare e Cellulare, Dipartimento di Medicina Interna, Università di Roma Tor Vergata, Roma, Italy.
Stem Cells (Impact Factor: 6.52). 12/2011; 29(12):2051-61. DOI: 10.1002/stem.763
Source: PubMed


Human heart harbors a population of resident progenitor cells that can be isolated by stem cell antigen-1 antibody and expanded in culture. These cells can differentiate into cardiomyocytes in vitro and contribute to cardiac regeneration in vivo. However, when directly injected as single cell suspension, less than 1%-5% survive and differentiate. Among the major causes of this failure are the distressing protocols used to culture in vitro and implant progenitor cells into damaged hearts. Human cardiac progenitors obtained from the auricles of patients were cultured as scaffoldless engineered tissues fabricated using temperature-responsive surfaces. In the engineered tissue, progenitor cells established proper three-dimensional intercellular relationships and were embedded in self-produced extracellular matrix preserving their phenotype and multipotency in the absence of significant apoptosis. After engineered tissues were leant on visceral pericardium, a number of cells migrated into the murine myocardium and in the vascular walls, where they integrated in the respective textures.
The study demonstrates the suitability of such an approach to deliver stem cells to the myocardium. Interestingly, the successful delivery of cells in murine healthy hearts suggests that myocardium displays a continued cell cupidity that is strictly regulated by the limited release of progenitor cells by the adopted source. When an unregulated cell source is added to the system, cells are delivered to the myocardium. The exploitation of this novel concept may pave the way to the setup of new protocols in cardiac cell therapy. STEM CELLS 2011;29:2051–2061.

Download full-text


Available from: Carmine Nicoletti
  • Source
    • "Neonatal cardiomyocytes (nCMs) Acc e p ted P r e p r i nt were isolated from hearts of 1-3-day-old FVB/N mice, as indicated in the manufacturer's instructions (kit by Worthington Biochemical Corp.). Briefly as reported in our previous publication (Forte et al., 2011), immediately after isolation, cells were pre-plated for 2 h 30 min to recover the non-adherent-enriched fraction of nCMs, which were then seeded on fibronectin (2 mg/mL; Sigma-Aldrich), laminin (0.2%), gelatin (0.02%) pre-coated plates. Adherent cells were expanded when subconfluent up to two times. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In tissue engineering, several factors play key roles in providing adequate stimuli for cells differentiation, in particular biochemical and physical stimuli, which try to mimic the physiological microenvironments. Since electrical stimuli are important in the developing heart, we have developed an easy-to-use, cost-effective cell culture platform, able to provide controlled electrical stimulation aimed at investigating the influence of the electric field in the stem cell differentiation process. This bioreactor consists of an electrical stimulator and twelve independent, petri-like culture chambers and a 3-D computational model was used to characterize the distribution and the intensity of the electric field generated in the cell culture volume. We explored the effects of monophasic and biphasic square wave pulse stimulation on a mouse adipose-derived stem cell line (m17.ASC) comparing cell viability, proliferation, protein and gene expression. Both monophasic (8V, 2ms, 1Hz) and biphasic (+4V, 1ms and -4V, 1ms; 1Hz) stimulation were compatible with cell survival and proliferation. Biphasic stimulation induced the expression of Connexin 43, which was found to localize also at the cell membrane, which is its recognized functional mediating intercellular electrical coupling. Electrically stimulated cells showed an induced transcriptional profile more closely related to that of neonatal cadiomyocytes, particularly for biphasic stimulation. The developed platform thus allowed to set-up precise conditions to drive adult stem cells toward a myocardial phenotype solely by physical stimuli, in the absence of exogenously added expensive bioactive molecules, and can thus represent a valuable tool for translational applications for heart tissue engineering and regeneration. Biotechnol. Bioeng. © 2014 Wiley Periodicals, Inc.
    Full-text · Article · Jul 2014 · Biotechnology and Bioengineering
  • Source
    • "More importantly, the benefits of MSC-based therapy have mainly been ascribed to their ability to generate endothelial cells and exert pro-angiogenic and cardioprotective effects by paracrine mechanisms rather than to direct the generation of new contractile cells (Gnecchi et al., 2008; Meyer et al., 2009; Wöhrle et al., 2010; Loffredo et al., 2011). Among the adult stem cell subsets so far proposed for cardiac muscle repair, resident cardiac stem/progenitor cells (CSCs or CPCs) were shown to retain the ability to differentiate into all the cardiac tissue cell types (Beltrami et al., 2003; Forte et al., 2011) and favor cardiac healing by direct production of contractile cells in vivo (Smits et al., 2009a,b). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The vascularization of tissue engineered products represents a key issue in regenerative medicine which needs to be addressed before the translation of these protocols to the bedside can be foreseen. Here we propose a multistep procedure to prepare pre-vascularized three-dimensional (3D) cardiac bio-substitutes using dynamic cell cultures and highly porous biocompatible gelatin scaffolds. The strategy adopted exploits the peculiar differentiation potential of two distinct subsets of adult stem cells to obtain human vascularized 3D cardiac tissues. In the first step of the procedure, human mesenchymal stem cells (hMSCs) are seeded onto gelatin scaffolds to provide interconnected vessel-like structures, while human cardiomyocyte progenitor cells (hCMPCs) are stimulated in vitro to obtain their commitment toward the cardiac phenotype. The use of a modular bioreactor allows the perfusion of the whole scaffold, providing superior performance in terms of cardiac tissue maturation and cell survival. Both the cell culture on natural-derived polymers and the continuous medium perfusion of the scaffold led to the formation of a densely packaged proto-tissue composed of vascular-like and cardiac-like cells, which might complete maturation process and interconnect with native tissue upon in vivo implantation. In conclusion, the data obtained through the approach here proposed highlight the importance to provide stem cells with complementary signals in vitro able to resemble the complexity of cardiac microenvironment.
    Full-text · Article · Jun 2014 · Frontiers in Physiology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Regeneration of myocardium through regenerative therapy and tissue engineering is appearing as a prospective treatment modality for patients with end-stage heart failure. Focusing on this area, this review highlights the new developments and challenges in the regeneration of myocardial tissue. The role of various cell sources, calcium ion and cytokine on the functional performance of regenerative therapy is discussed. The evolution of tissue engineering and the role of tissue matrix/scaffold, cell adhesion and vascularisation on tissue engineering of cardiac tissue implant are also discussed.
    Full-text · Article · Jan 2012 · Biomatter
Show more